Vor Biopharma (VOR) EPS (Diluted) (2021 - 2026)

Vor Biopharma (VOR) EPS (Diluted) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 0.00
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.15
4 NuCana 279.75 Bn 279.75 Bn - -368,323.02
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 4.02
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 6.75
7 Belite Bio 62.51 Bn 62.51 Bn - 0.00
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 7.33
9 Revolution Medicines 37.78 Bn 37.78 Bn - -2.29
10 Vor Biopharma 187.37 Mn 187.37 Mn - -0.73

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.73
Dec 31, 2025 -3.37
Sep 30, 2025 -121.63
Jun 30, 2025 -251.24
Mar 31, 2025 -5.21
Dec 31, 2024 -9.43
Sep 30, 2024 -8.05
Jun 30, 2024 -8.15
Mar 31, 2024 -9.06
Dec 31, 2023 -7.82
Sep 30, 2023 -9.82
Jun 30, 2023 -8.94
Mar 31, 2023 -8.58
Dec 31, 2022 -12.09
Sep 30, 2022 -12.52
Jun 30, 2022 -11.57
Mar 31, 2022 -12.19
Dec 31, 2021 -10.92
Sep 30, 2021 -10.05
Jun 30, 2021 -9.97